| ¿µ¹® | screening | ÇÑ±Û | °Ë»ö, ¼±º° |
|---|---|---|---|
| ¼³¸í | 1. º¸±â¿¡´Â °Ç°ÇÑ °Í°ú °°ÀÌ º¸ÀÌ¸é¼ Áúº´¿¡ °É·ÁÀÖ´Ù°í »ý°¢µÇ´Â »ç¶÷µéÀ» °ñ¶ó³»±â À§ÇÑ °Ë»ç. Áúº´ÀÇ Áø´ÜÀ» ÀǵµÇÑ °ÍÀº ¾Æ´Ï°í ´Ù¼öÀÇ ¼öÀüÀÚ Áß¿¡¼ ºñ±³Àû °£´ÜÇÑ ¹æ¹ýÀ¸·Î ÀǽÉÀÌ °¡´Â ÀÚ¸¦ °ñ¶ó³»´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. ¼±ÃâµÈ ÀÚ´Â ´õ¿í »ó¼¼ÇÑ °Ë»ç¸¦ ¹ÞÀ» Çʿ䰡 ÀÖ´Ù. 2. ½ÃÇèÀ̳ª °Ë»ç¿Í °°Àº ¿¹ºñÀû ÀýÂ÷, Á¶»ç°¡ ´õ ÇÊ¿äÇÑ Àå¾ÖÀÇ °¡Àå Æ¯Â¡ÀûÀΠ¡Èĸ¦ ã¾Æ³»±â À§ÇØ ½ÃÇàÇÑ´Ù. 3. Áý´Ü¼±º°°Ë»ç, °íÇ÷¾Ð°ú °°Àº ƯÁ¤º´À̳ª Àå¾Ö¸¦ ã¾Æ³»±â À§ÇØ Å« Ç¥º»À» ÀÌ¿ëÇÏ´Â °Ë»ç. |
||
| ¿µ¹® | newborn infant | ÇÑ±Û | ½Å»ý¾Æ |
|---|---|---|---|
| ¼³¸í | ºÐ¸¸ Á÷ÈĺÎÅÍ µ¶¸³µÈ ÀÚ±ÃÀÇ »ýȰÀ» ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» ȹµæÇÒ ¶§±îÁöÀÇ ¾ÆÀÌ. ½Å»ý¾Æ´Â »ýÈÄ 4ÁÖÀϱîÁö¸¦ ¸»ÇÑ´Ù. ÀÌ ±â°£¿¡ ½Å»ý¾Æ´Â ¸ðüÀÇ Å ¾È¿¡¼ ÀÚµ¿ÀûÀ¸·Î »ê¼Ò³ª ¿µ¾çÀ» ¹Þ°í ÀÖ´ø »óÅ¿¡¼ ÀÚ·ÂÀ¸·Î È£ÈíÀ̳ª ¿µ¾ç ¼·Ã븦 ÇÏ°Ô µÇ´Â ±Þ°ÝÇÑ º¯È°¡ ÀϾ°í, ÀÌ¿¡ µû¶ó¼ ÃʱâÀÇ Ã¼¿ÂÀÇ °ÇÏ, »ý¸®Àû üÁßÀÇ °¨¼Ò, ½Å»ý¾ÆÈ²´Þ, ÅÈÁÙÀÇ Å»¶ô µîÀÇ ¿©·¯ Çö»óÀÌ ÀϾÙ. °¨°¢¸é¿¡¼´Â ¿µ¾ç ¼·Ã븦 À§ÇÑ ÈíÀιݻç´Â Àß ¹ß´ÞµÇ¾î ÀÖÀ¸³ª, ¹Ì°¢Àº ´ë°ÀÇ ¸ÀÀÇ ÆÇº°, Èİ¢Àº °ÇÑ ¾ÇÃë¿¡ ´ëÇÑ ¹ÝÀÀ, ½Ã°¢Àº ¸í¾ÏÀ» ÆÇº°ÇÏ´Â Á¤µµÀ̸ç, û°¢Àº »ýÈÄ 1ÁÖÀϰæ±îÁö´Â °ÅÀÇ ¹ÝÀÀÀ» ³ªÅ¸³»Áö ¾Ê´Â´Ù. |
||
| ¿µ¹® | hemolytic disease of newborn | ÇÑ±Û | ½Å»ý¾Æ¿ëÇ÷º´ |
|---|---|---|---|
| ¼³¸í | ½Å»ý¾Æ¿¡¼ ÀûÇ÷±¸°¡ ºñÁ¤»óÀûÀ¸·Î ¸¹ÀÌ ÆÄ±«µÇ´Â º´À¸·Î žÆÀû¸ð±¸Áõ(erythroblastosis fetalis)¿Í °°Àº ¶æÀ¸·Î ¾²ÀδÙ. À̰ÍÀº ¾î¸Ó´Ï¿¡°Ô¼ »ý»êµÈ ½Å»ý¾Æ³ª žÆÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ ŹÝÀ» °Ç³Ê¿Í¼ žÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÇÏ¿©¼ »ý±â´Â ¿ëÇ÷¼ººóÇ÷À» À̸£´Â ¸». Áï ½Å»ý¾Æ³ª žÆÀÇ ÀûÇ÷±¸ÀÇ Ç×ü°¡ ¾î¸Ó´ÏÀÇ ¸ö¿¡¼ »ý»êÀÌ µÇ°í À̰ÍÀÌ Å¹ÝÀ» ÅëÇØ¼ žƿ¡°Ô ³Ñ¾î°¡¼ žÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» Çϰí ÀÌ Ç×ü¿Í °áÇÕÇÑ ÀûÇ÷±¸´Â ÆÄ±«°¡ µÇ¾î¼ ºóÇ÷ÀÌ »ý±ä °ÍÀ» žÆÀû¸ð±¸ÁõÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Rh Àû¸ð±¸Áõ(Rh erythroblastosis)¿Í ABO Àû¸ð±¸Áõ(ABO erythroblastosis)·Î ³ª´ ¼ö°¡ ÀÖ´Ù. |
||
| ¿µ¹® | hearing | ÇÑ±Û | µè±â, û°¢, û·Â |
|---|---|---|---|
| ¼³¸í | ¾î¶² ¹üÀ§ÀÇ Á֯ļöÀÇ À½ÆÄ°¡ û°¢±â¸¦ ÀÚ±ØÇÏ¿© »ý±â´Â °¨°¢. À½ÆÄÀÇ Á֯ļö´Â 20Hz¿¡¼ 2¸¸ Hz(1Hz´Â ¸ÅÃÊ 1»çÀÌŬ)±îÁöÀ̰í, û°¢±â°üÀº ¹Ù±ù±Í-°¡¿îµ¥±Í-¼Ó±Í·Î ±¸ºÐµÈ´Ù. û°¢ ¼ö¿ë±â´Â ¼Ó±ÍÀÇ ´ÞÆØÀ̰ü¿¡ ÀÖ°í, ¹Ù±ù±Í ¹× °¡¿îµ¥±Í´Â À½À» ¼Ó±Í¿¡ Àü´ÞÇÏ´Â ÀüÀ½±âîîëåÐïÀÌ´Ù. ¹Ù±ù±Í´Â ±Ó¹ÙÄû¿Í ¹Ù±ù±Í±æ·Î ÀÌ·ç¾îÁ® ÀÖÀ¸¸ç, °í¸·ÀÌ °¡¿îµ¥±Í¿ÍÀÇ °æ°è¸¦ ÀÌ·é´Ù. °¡¿îµ¥±Í´Â ¸ÁÄ¡»À-¸ð·ç»À-µîÀÚ»À¶ó°í ÇÏ´Â ¼¼ °³ÀÇ ±Ó¼Ó»À°¡ ÀÖ¾î °í¸·ÀÇ Áøµ¿À» ´ÞÆØÀ̰üÀÇ ¾È¶ãâ¿¡ Àü´ÞÇÑ´Ù. ÀÌ ¶§ À½ÆÄÀÇ ÁøÆøÀº °¨¼èµÇÁö¸¸ À½¾ÐÀº ¾à 20¹è·Î Áõ°µÈ´Ù. ´ÞÆØÀ̰üÀº Á¶°³²®µ¥±âÀÇ ³ª»ç ¸ð¾çÀÇ °ñ°üÀ̸ç, Ⱦ´Ü¸é¿¡¼´Â ±âÀú¸·°ú ¾È¶ã¸·¿¡ ÀÇÇØ ¼¼ ¹æÀ¸·Î ³ª´©¾îÁø´Ù. ¾ç¸·À¸·Î µÑ·¯½ÎÀÎ ºÎºÐÀÌ ´ÞÆØÀ̰üÀε¥ ³»¸²ÇÁ·Î °¡µæ Â÷ ÀÖ°í, ±× À§¿¡ ÀÖ´Â ¾È¶ã°è¿Í ¹Ø¿¡ ÀÖ´Â °í½Ç°è´Â ¿Ü¸²ÇÁ·Î °¡µæ Â÷ ÀÖ´Ù. ±âÀú¸· À§¿¡´Â Åм¼Æ÷°¡ ¹è¿µÇ¾î ÀÖ´Ù. ¾È¶ãâ¿¡ Àü´ÞµÈ À½ÆÄ´Â ¾È¶ã°èÀÇ ¿Ü¸²ÇÁ¸¦ ÅëÇØ¼ ´ÞÆØÀ̼¼°üÀÇ ³»¸²ÇÁ·Î ÀüÇØÁö°í ³¡¿¡ °¡¼´Â ±âÀú¸· À§¿¡ Åм¼Æ÷¿¡ Áøµ¿ÀÚ±ØÀ» ÁÖ°Ô µÈ´Ù. Åм¼Æ÷°¡ ÈïºÐÇÏ¸é ¿©±â¿¡ ºÎÂøÇØ ÀÖ´Â ´ÞÆØÀ̰ü½Å°æÀ¸·Î Ãæµ¿ÀÌ ¹ß»çµÈ´Ù. ´ÞÆØÀ̰ü ½Å°æÀº Á¦8³ú½Å°æÀÇ ÀϺημ ¼û³ú¿¡ µé¾î°¡ ¼û³úÀÇ ¿Ã¸®ºêÇÙ, Áß°£³úÀÇ ¾Æ·¡¾ð´ö, ¾ÈÂʹ«¸Ã¼¿¡ ÀÇÇØ¼ ¿¬Á¢Àü´ÞÀ» ÇÏ¿© ´ë³ú°ÑÁú °üÀÚ¿±ÀÇ Ã»°¢ºÎ¿¡ À̸£·¯ û°¢À» ¹ß»ý½ÃŲ´Ù. |
||
| ¿µ¹® | hearing aid | ÇÑ±Û | º¸Ã»±â |
|---|---|---|---|
| ¼³¸í | ÀÏÁ¾ÀÇ È®¼ºÀåÄ¡·Î¼ ³Ã»À» º¸ÃæÇϱâ À§ÇØ ±Í¿¡ ÀåÂøÇÏ´Â ±â±¸. ¿¾³¯¿¡´Â ³ªÆÈÇüÀÇ ÁýÀ½±â¿´´ø °ÍÀÌ Áö±ÝÀº º¸Åë À½ÀÇ ÁõÆøÀ» µ½´Â Àü±âº¸Ã»±â°¡ ¾²ÀδÙ. ²ÀÁö¿¡ ÀåÂøÇÏ´Â »ÀÀüµµµµ ÀÖÀ¸³ª ´ë°³´Â °ø±âÀü½ÄÀ¸·Î µÈ °ÍÀÌ ¸¹´Ù. Áï, À½ÆÄ¸¦ ¸¶ÀÌÅ©·ÎÆùÀ¸·Î ¹Þ¾Æ Àü±âÁøµ¿À¸·Î ¹Ù²Ù¾î À̰ÍÀ» ÁõÆø±â·Î È®´ëÇÏ¿© À̾îÆùÀ¸·Î ´Ù½Ã À½ÆÄ·Î ¸¸µé¾î ±Í¿¡ µé¸®°Ô ÇÑ´Ù. ³Ã» °¡¿îµ¥¼µµ ÀüÀ½¼º ³Ã»¿¡´Â È¿°ú°¡ ÀÖÀ¸³ª, ½Å°æ°è ±â´ÉÀúÇϰ¡ ¿øÀÎÀÎ ¼Ó±Í¿Í °ü·ÃµÈ °¨À½¼º ³Ã»¿¡´Â º°·Î È¿°ú¸¦ ±â´ëÇÒ ¼ö ¾ø´Ù. º¸Ã»±âÀÇ »ç¿ëÇѰè´Â Àß µé¸®´Â ÂÊ ±ÍÀÇ Æò±Õû·Â¼Õ½Ç 30dB(Á¤»óû·ÂÀÇ 1/30)À» ±âÁØÀ¸·Î ÇÏ¿© À̺¸´Ù °æµµÀÏ ¶§´Â Çʿ䰡 ¾ø°í ±× ÀÌ»óÀÇ Àå¾Ö°¡ ÀÖÀ» ¶§ Àû¿ëµÈ´Ù. º¸Ã»±â´Â Æ®·£Áö½ºÅÍ¿¡¼ IC ȸ·Î·Î ÀüÀÚ±â¼úÀÇ ÁøÀü°ú ÇÔ²² °³·®µÇ¾î °¨µµµµ ÁÁÀ»»Ó´õ·¯ ¾ÆÁÖ ÀÛ¾ÆÁö°í, ÁõÆøÀåÄ¡ºÎ¸¦ ¿©·¯ ÇüÅ·Π¸¸µç °ÍÀÌ ÆÇ¸ÅµÇ°í ÀÖ´Ù. ¿¹¸¦ µé¸é, ¾È°æÅ׿¡ ¼¼Æ®µÇ¾î ÀÖ´Â ¾È°æÇü, ±Í¿¡ °É°Ô µÇ¾î ÀÖ´Â ±ÍµÚÇü, ¿©ÀÚÀÇ ¸Ó¸®ÇÉ ÇüÀ̳ª ³ØÅ¸ÀÌÇÉ Çü, Æ÷ÄÏÇü µîÀÌ ÀÖ´Ù. |
||
| DAST | drug abuse screening test; drug and alcohol screening test |
|---|---|
| HHIE-S | Hearing Handicap Inventory for the Elderly-Screening Version |
| HL | hairline; hairy leukoplakia; half life; hearing level; hearing loss; heparin lock; histiocytic lymph... |
| HT | Hashimoto thyroiditis; hearing test; hearing threshold; heart; heart transplantation, heart transpla... |
| HDN | Hemolytic Disease of Newborn |
| UNHS | Universal newborn hearing screening |
|---|---|
| HDN | Haemolytic disease of the newborn |
| HDN | Hemorrhagic Disease of the Newborn |
| N.I.C.U. | Newborn Intensive Care Unit |
| NBS | Newborn bovine serum |
| newborn screening | Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism. (12 Dec 1998) |
|---|---|
| cancer, colon: screening and surveillance | Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer. (12 Dec 1998) |
| genetic screening | The process of testing individuals to find out if they carry genes for certain known genetic diseases, such as sickle cell anaemia. (09 Oct 1997) |
| carrier screening | Indiscriminate examination of members of a population to detect heterozygotes for serious disorders and counsel about the risks of marriages with other carriers, and by antenatal diagnosis where a married couple are both carriers; often sacrifices precision to simplicity and is most effectively applied to populations known to be at high risk. (05 Mar 2000) |
| mass screening | Organised periodic procedures performed on large groups of people for the purpose of detecting disease. (12 Dec 1998) |
| vision screening | Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from vision tests, which are given to evaluate/measure individual visual performance not related to a specific population. (12 Dec 1998) |
| multiphasic screening | The simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people. (12 Dec 1998) |
| prenatal screening | Screening for the detection of foetal disease, usually by ultrasound examination or by testing amniotic fluid obtained by amniocentesis. Other screening techniques include testing maternal serum and placental biopsy. (05 Mar 2000) |
| cytologic screening | A screening for the detection of early disease, usually cancer, through microscopic examination of a cellular specimen by inspecting each cell and structure present, usually at ×100 magnification with a mechanical stage, so that all areas are screened; the findings are evaluated and significant abnormalities are flagged (e.g., by dotting the cover slip) for further evaluation by a cytopathologist. This screening is usually performed by a cytotechnologist, but at times is done by automated machine prescreening. (05 Mar 2000) |
| screening | Examination of people with no symptoms, to detect unsuspected disease. (16 Dec 1997) |
| screening audiometry | Rapid measurement of the hearing of an individual or a group against a predetermined limit of normalcy; auditory responses to different frequencies presented at a constant intensity level are tested. (05 Mar 2000) |
| screening test | Any testing procedure designed to separate people or objects according to a fixed characteristic or property. (05 Mar 2000) |
| neonatal screening | The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic. (12 Dec 1998) |
| Denver Developmental Screening Test | A scale used by psychologists and paediatricians to assess the developmental, intellectual, motor, and social maturity of children at any age level from birth to adolescence. (05 Mar 2000) |
| differential screening | Process in development of a multicellular organism by which cells become specialised for particular functions. Requires that there is selective expression of portions of the genome, the fully differentiated state may be preceded by a stage in which the cell is already programmed for differentiation but is not yet expressing the characteristic phenotype determination. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|